TDEM will also launch a regional infusion center for the Rio Grande Valley tomorrow, August 14, in Harlingen. This past week, TDEM expanded operations at the existing regional infusion center in Lubbock. More infusion centers will be launched throughout the state as additional needs are identified based on factors such as COVID-19 case data and existing resources.
“Antibody infusion centers play an integral role in our efforts to combat COVID-19 because they help prevent hospitalizations and ensure that resources are available to treat the most severe cases of this virus,” said Governor Abbott. “Thank you to our local partners for working with the State of Texas to launch these centers across Texas. We will continue to work with local leaders to ensure our communities have the support they need to keep Texans safe and healthy.”
These infusion centers, equipped with Regeneron’s monoclonal antibodies, will treat COVID-19 patients who do not need hospitalization with therapeutic drugs that can prevent their condition from worsening and requiring hospital care. These centers also help increase bed capacity in hospitals so that resources are available for the most ill patients. The State deployed similar measures in early 2021 to communities across Texas. Patients must meet certain criteria and have a referral from a doctor.
Source: gov.texas.gov
